REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 20th, 2022 • Celularity Inc • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of May 20, 2022, between Celularity Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 20th, 2022 • Celularity Inc • Pharmaceutical preparations • New York
Celularity Inc.Celularity Inc • May 20th, 2022 • Pharmaceutical preparations • New York
FORM OF COMMON STOCK PURCHASE WARRANT CELULARITY INC.Celularity Inc • May 20th, 2022 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_________________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May 20, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 20, 2027 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Celularity Inc., a Delaware corporation (the “Company”), up to [______] shares of Class A common stock, par value $0.0001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
